SEALSQ Corp (NASDAQ: LAES) VP discloses 30,000-share stock option stake

Rhea-AI Filing Summary

SEALSQ Corp executive Enguent Jean-Pierre, Vice President of R&DSS, filed an initial ownership report showing a direct holding of employee stock options. These options cover 30,000 ordinary shares at an exercise price of 0.0100 per share and expire on 2032-04-30. This filing records existing derivative holdings rather than a new market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Enguent Jean-Pierre

Role Vice President, R&DSS

Type	Security	Shares	Price	Value
holding	Employee Stock Option Plan (right to buy)	--	--	--

Holdings After Transaction: Employee Stock Option Plan (right to buy) — 30,000 shares (Direct)

Footnotes (1)

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Enguent Jean-Pierre

(Last) (First) (Middle)

C/O SEALSQ CORP

AVENUE LOUIS-CASAI 58

(Street)

COINTRIN 1216

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SEALSQ Corp [ LAES ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President, R&DSS

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option Plan (right to buy)	02/10/2026	04/30/2032	Ordinary Shares	30,000	$0.01	D

Explanation of Responses:

	/s/ John O'Hara, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does SEALSQ Corp (LAES) report in this Form 3 filing?

The Form 3 shows Vice President of R&DSS Enguent Jean-Pierre holding employee stock options over 30,000 ordinary shares. These derivative holdings are reported as an initial ownership statement, not as a new market transaction or trade.

How many SEALSQ (LAES) shares are covered by Enguent Jean-Pierre’s options?

Enguent Jean-Pierre’s employee stock options cover 30,000 ordinary shares of SEALSQ Corp. This represents the underlying share amount tied to his option position, as reported in the initial ownership statement on Form 3.

What is the exercise price of the SEALSQ (LAES) options reported on Form 3?

The employee stock options reported carry an exercise price of 0.0100 per share. This is the price at which Enguent Jean-Pierre can buy SEALSQ ordinary shares under the option plan if he chooses to exercise.

When do Enguent Jean-Pierre’s SEALSQ (LAES) stock options expire?

The reported employee stock options expire on 2032-04-30. This means the right to purchase the underlying SEALSQ ordinary shares at the stated exercise price lasts until that expiration date, assuming other plan conditions are met.

Is the SEALSQ (LAES) Form 3 a buy or sell transaction?

The Form 3 does not report a buy or sell; it records existing holdings. It lists Enguent Jean-Pierre’s direct employee stock options over 30,000 ordinary shares as an initial ownership position rather than a new market trade.